Pluri Inc.

Informe acción NasdaqCM:PLUR

Capitalización de mercado: US$33.5m

Salud financiera de hoja de balance de Pluri

Salud financiera controles de criterios 4/6

Pluri tiene un patrimonio de los accionistas total de $6.6M y una deuda total de $24.4M, lo que sitúa su ratio deuda-patrimonio en 368.8%. Sus activos y pasivos totales son $41.6M y $34.9M respectivamente.

Información clave

1,304.3%

Ratio deuda-patrimonio

US$24.07m

Deuda

Ratio de cobertura de interesesn/a
EfectivoUS$26.01m
PatrimonioUS$1.85m
Total pasivoUS$34.55m
Activos totalesUS$36.39m

Actualizaciones recientes sobre salud financiera

Pluristem Therapeutics (NASDAQ:PSTI) Has Debt But No Earnings; Should You Worry?

Dec 04
Pluristem Therapeutics (NASDAQ:PSTI) Has Debt But No Earnings; Should You Worry?

We Think Pluristem Therapeutics (NASDAQ:PSTI) Needs To Drive Business Growth Carefully

Aug 18
We Think Pluristem Therapeutics (NASDAQ:PSTI) Needs To Drive Business Growth Carefully

We're Hopeful That Pluristem Therapeutics (NASDAQ:PSTI) Will Use Its Cash Wisely

Feb 08
We're Hopeful That Pluristem Therapeutics (NASDAQ:PSTI) Will Use Its Cash Wisely

Recent updates

Pluri gains as PROTO project receives €7.5M EU grant

Sep 06

Pluristem Therapeutics renames as Pluri

Jul 25

Pluristem Therapeutics (NASDAQ:PSTI) Has Debt But No Earnings; Should You Worry?

Dec 04
Pluristem Therapeutics (NASDAQ:PSTI) Has Debt But No Earnings; Should You Worry?

We Think Pluristem Therapeutics (NASDAQ:PSTI) Needs To Drive Business Growth Carefully

Aug 18
We Think Pluristem Therapeutics (NASDAQ:PSTI) Needs To Drive Business Growth Carefully

What Is The Ownership Structure Like For Pluristem Therapeutics Inc. (NASDAQ:PSTI)?

Mar 15
What Is The Ownership Structure Like For Pluristem Therapeutics Inc. (NASDAQ:PSTI)?

We're Hopeful That Pluristem Therapeutics (NASDAQ:PSTI) Will Use Its Cash Wisely

Feb 08
We're Hopeful That Pluristem Therapeutics (NASDAQ:PSTI) Will Use Its Cash Wisely

Pluristem Therapeutics launches $30M registered direct offering

Feb 02

Have Insiders Been Buying Pluristem Therapeutics Inc. (NASDAQ:PSTI) Shares?

Jan 04
Have Insiders Been Buying Pluristem Therapeutics Inc. (NASDAQ:PSTI) Shares?

Pluristem expands COVID-19 program in Mexico

Dec 29

Pluristem - Moment Of Truth

Dec 08

Market Sentiment Around Loss-Making Pluristem Therapeutics Inc. (NASDAQ:PSTI)

Nov 30
Market Sentiment Around Loss-Making Pluristem Therapeutics Inc. (NASDAQ:PSTI)

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($32.3M) de PLUR superan a sus pasivos a corto plazo ($4.5M).

Pasivo a largo plazo: Los activos a corto plazo ($27.4M) de PLUR no cubren sus pasivos a largo plazo ($30.0M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: PLUR tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de PLUR ha crecido de 0% a 368.8% en los últimos 5 años.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: PLUR tiene suficiente cash runway para más de un año basándose en su flujo de caja libre actual.

Pronóstico de cash runway: PLUR dispone de suficiente cash runway para 1.3 años si el flujo de caja libre sigue reduciéndose a tasas históricas de 2.6% cada año.


Descubre empresas con salud financiera